In order to confirm this, we determined Trx and TXNIP expression in three established GBM cell lines—U87, U251, and U373—and primary GBM cells, which have previously been shown by us to be intrinsically resistant to TMZ and cisplatin [30]. The gene discussed is TXN; the disease is glioblastoma.